TechNavio's analysts forecast the Global Next Generation Sequencing market to grow at a CAGR of 20.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of next generation sequencing by new customers. The Global Next Generation Sequencing market has also been witnessing an introduction of new DNA sequencing products and accessories. However, the logistical problems could pose a challenge to the growth of this market.... Research Beam Model: Research Beam Product ID: 17044 2500 USD New
Global Next Generation Sequencing Market 2012-2016
 
 

Global Next Generation Sequencing Market 2012-2016

  • Category : Consumer Goods
  • Published On : September   2013
  • Pages : 117
  • Publisher : Technavio
 
 
 

TechNavio's analysts forecast the Global Next Generation Sequencing market to grow at a CAGR of 20.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of next generation sequencing by new customers. The Global Next Generation Sequencing market has also been witnessing an introduction of new DNA sequencing products and accessories. However, the logistical problems could pose a challenge to the growth of this market. 

TechNavio's report, Global Next Generation Sequencing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Next Generation Sequencing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Illumina Inc., Life Technologies Corp., Roche Holding AG, and Pacific Biosciences of California Inc.

The other vendors mentioned in the report are 23andMe Inc., Ambry Genetics Corp., Axeq Technologies Inc., Beijing Genomics Institute, GeneDx, Fluidigm Corp., Foundation Medicine Inc., Good Start Genetics Inc., Helicos BioSciences Corp., Knome Inc., NABsys Inc., Oxford Nanopore Technologies Ltd., Pathogenica Inc., QIAGEN N.V, RainDance Technologies Inc., Sequenom Inc., Takara Bio Inc. 

Key questions answered in this report:

What will the market size be in 2016 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of these key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


 



 


 



01. Executive Summary

02. Scope of the Report


02.1 Market Overview

02.2 Product Offerings

03. Market Research Methodology

03.1 Market Research Process

03.2 Research Design

03.3 Research Methodology

04. List of Abbreviations

05. Introduction

06. Market Landscape


06.1 Market Overview

06.2 Market Size and Forecast

06.3 Next Generation Sequencing Market in the US

06.3.1 Market Size and Forecast

06.4 Next Generation Sequencing Market in Europe

06.4.1 Market Size and Forecast

06.4.2 Top Five Next Generation Sequencing Instruments in Europe

06.5 Next Generation Sequencing Market in Japan

06.5.1 Market Size and Forecast

06.6 Five Forces Analysis

07. Market Segmentation by Application

08. Market Segmentation by Technology


08.1.1 Sequencing by Synthesis

08.1.2 Ion Semiconductor Sequencing

08.1.3 Sequencing by Ligation

08.1.4 Pyrosequencing

08.1.5 SMRT Sequencing

08.2 Comparison of Various Technologies

09. Market Segmentation by Product

09.1 Global Next Generation Sequencing Market by Product Snapshot

09.2 Global Next Generation Sequencing Market by Reagents

09.2.1 Market Size and Forecast

09.3 Global Next Generation Sequencing Market by Instruments

09.3.1 Market Size and Forecast

09.3.2 Price of Next Generation Instruments

09.3.3 Market Segmentation

09.4 Global Next Generation Sequencing Market by Services

09.4.1 Market Size and Forecast

09.5 Global Next Generation Sequencing Market by Product 2012-2016 (in percentage)

09.6 Global Next Generation Sequencing Market by Product Growth Rate

10. Market Segmentation by End-users

10.1 Global Next Generation Sequencing Market by End-users Snapshot

10.2 Global Next Generation Sequencing Market by Academia

10.2.1 Market Size and Forecast

10.3 Global Next Generation Sequencing Market by Biopharma

10.3.1 Market Size and Forecast

10.4 Global Next Generation Sequencing Market by Applied Markets

10.4.1 Market Size and Forecast

10.5 Global Next Generation Sequencing Market by Clinical Customers

10.5.1 Market Size and Forecast

10.6 Global Next Generation Sequencing Market by End-users Growth Rate

11. Geographical Segmentation

11.1 Global Next Generation Sequencing Market by Geographical Segmentation 2012-2016

11.2 Global Next Generation Sequencing Market by Geographical Segmentation Snapshot

11.3 Next Generation Sequencing Market in the Americas

11.3.1 Market Size and Forecast

11.4 Next Generation Sequencing Market in the EMEA Region

11.4.1 Market Size and Forecast

11.5 Next Generation Sequencing Market in the APAC Region

11.5.1 Market Size and Forecast

11.6 Global Next Generation Sequencing Market by Geographical Segmentation 2012-2016

12. Key Leading Countries

12.1 USA

12.2 UK

12.3 Japan

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape


20.1 Competitive Scenario

20.1.1 Key News

20.1.2 Mergers and Acquisitions

20.2 Market Share Analysis 2012

20.3 Other Prominent Vendors

21. Key Vendor Analysis

21.1 Beijing Genome Institute

21.1.1 Business Overview

21.1.2 Business Segmentation

21.1.3 Key Information

21.1.4 SWOT Analysis

21.2 Illumina Inc.

21.2.1 Business Overview

21.2.2 Business Segmentation

21.2.3 Specifications and Costs of Roche Platforms and Associated Reagents

21.2.4 Key Information

21.2.5 SWOT Analysis

21.3 Life Technologies Corp.

21.3.1 Business overview

21.3.2 Business Segmentation

21.3.3 Specifications and Costs of Life Technologies Platforms and Associated Reagents

21.3.4 Key Information

21.3.5 SWOT Analysis

21.4 Pacific Biosciences of California Inc.

21.4.1 Business Overview

21.4.2 Business Segmentation

21.4.3 Key Information

21.4.4 SWOT Analysis

21.5 QIAGEN N.V.

21.5.1 Business Overview

21.5.2 Business Segmentation

21.5.3 Key Information

21.5.4 SWOT Analysis

21.6 Roche Holding Ltd.

21.6.1 Business Overview

21.6.2 Business Segmentation

21.6.3 Specifications and Costs of Roche Platforms and Associated Reagents

21.6.4 Key Information

21.6.5 SWOT Analysis

22. Other Reports in this Series

 

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Next Generation Sequencing Market Segmentation

Exhibit 3: Global Genomics Market Segmentation

Exhibit 4: Global Genomics Market Segmentation

Exhibit 5: Global Next Generation Sequencing Market 2012-2016 (US$ million)

Exhibit 6: Next Generation Sequencing Market in the US 2012-2016 (US$ million)

Exhibit 7: Next Generation Sequencing Market in Europe 2012-2016 (US$ million)

Exhibit 8: Next Generation Sequencing Market in Japan 2012-2016 (US$ million)

Exhibit 9: Global Next Generation Sequencing Market Segmentation by Application

Exhibit 10: Global Next Generation Sequencing Market Segmentation by Technology

Exhibit 11: Global Next Generation Sequencing Market Segmentation by Product

Exhibit 12: Global Next Generation Sequencing Market Segmentation by Product 2012

Exhibit 13: Global Next Generation Sequencing Market by Reagents 2012-2016 (US$ million)

Exhibit 14: Global Next Generation Sequencing Market by Instruments 2012-2016 (US$ million)

Exhibit 15: Global Next Generation Sequencing Market by Instruments Segmentation

Exhibit 16: Global Next Generation Sequencing Market by Instruments Segmentation 2012

Exhibit 17: Global Next Generation Sequencing Market by Services 2012-2016 (US$ million)

Exhibit 18: Global Next Generation Sequencing Market by Product 2012-2016 (in percentage)

Exhibit 19: Global Next Generation Sequencing Market by Product Growth Rate

Exhibit 20: Global Next Generation Sequencing Market Segmentation by End-users

Exhibit 21: Global Next Generation Sequencing Market Segmentation by End-users 2012

Exhibit 22: Global Next Generation Sequencing Market by Academia 2012-2016 (US$ million)

Exhibit 23: Global Next Generation Sequencing Market by Biopharma 2012-2016 (US$ million)

Exhibit 24: Global Next Generation Sequencing Market by Applied Markets 2012-2016 (US$ million)

Exhibit 25: Global Next Generation Sequencing Market by Clinical Customers 2012-2016 (US$ million)

Exhibit 26: Global Next Generation Sequencing Market by End-users Growth Rate 2012

Exhibit 27: Global Next Generation Sequencing Market by Geographical Segmentation 2012

Exhibit 28: Global Next Generation Sequencing Market in the Americas 2012-2016 (US$ million)

Exhibit 29: Global Next Generation Sequencing Market in the EMEA Region 2012-2016 (US$ million)

Exhibit 30: Global Next Generation Sequencing Market in the APAC Region 2012-2016 (US$ million)

Exhibit 31: Global Next Generation Sequencing Market by Geographical Segmentation 2012-2016 (in percentage)

Exhibit 32: Global Next Generation Sequencing Market by Vendor Segmentation 2012

Exhibit 33: Business Segmentation of Beijing Genomic Institute

Exhibit 34: Business Segmentation of Illumina Inc.

Exhibit 35: Business Segmentation of Life Technologies Corp.

Exhibit 36: Business Segmentation of Pacific Biosciences of California Inc.

Exhibit 37: Business Segmentation of QIAGEN N.V.

Exhibit 38: Business Segmentation of Roche Holding Ltd.



PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT